EQUITY RESEARCH MEMO

Regulatory Affairs Associates

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)72/100

Regulatory Affairs Associates (RAA) is a premier FDA consulting firm based in Ann Arbor, Michigan, with over three decades of experience guiding medical device, drug, and nutritional supplement companies through the regulatory approval process. Founded in 1988, RAA has built a strong reputation for optimizing approval efficiency, evidenced by a track record of securing over 240 government approvals globally and assisting in the launch of more than 200 new companies. The firm's deep expertise spans the entire regulatory lifecycle, from pre-submission strategy to post-market compliance, enabling clients to navigate complex FDA requirements with confidence. As the regulatory landscape evolves, RAA's established relationships with regulators and proven methodologies position it as a critical partner for companies seeking market access. The consulting firm's private, independent status allows it to offer unbiased, tailored solutions, making it a trusted resource in the highly specialized field of regulatory affairs.

Upcoming Catalysts (preview)

  • Q3 2026FDA Final Guidance on Software as a Medical Device (SaMD) Updates85% success
  • Q4 2026Expansion of Consulting Services to Biologics and Advanced Therapies60% success
  • Q2 2027Strategic Partnership with a Major Clinical Research Organization (CRO)40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)